InvestorsHub Logo

I-Glow

01/19/20 7:20 PM

#181470 RE: lar2 #181452

The psoriasis cream patent is worthless - it would be classified as a drug and OWCP hasn't started any clinical trials.

EXAMINATION OF CLINICAL TRIAL COSTS AND BARRIERS FOR DRUG DEVELOPMENT

For Phase 1, 2 and 3 the subtotal cost is $22.2 million.

FDA NDA/BLA Review Phase : $2.0 million

Phase 4: $25.2 million

Total: $49.3 million

We know that OWCP doesn't have the resources to fund drug development and Sheba Hospital isn't going to fund drug development and give half of it way.

There doesn't seem to be any logic when shareholders think a worthless patent is worth billions.

That is why serious investors won't touch OWCP - there isn't any rationale or logic behind the claims of a few shareholders.

Plus, real companies don't use toxic financing!

IG